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INTRODUCTION 
Diabetes mellitus is often recognized as a metabolic disease that 
depresses the anti-bacterial defenses of the host. Many clinical in-
vestigators have reported that patients with uncontrolled diabetes are 
unusually susceptible to bacterial disease. 
It appears that in the diabetic patient the function of leukocytes 
in inflammation is impaired. A decrease in glycolysis, inability of the 
diabetic leukocyte to phagocytize and a defect in leukotaxis can play a 
role in abnormal leukocyte function. These abnormalities of the leukocyte 
could contribute to increased infections in the uncontrolled diabetic pa-
tient. 
The evidence that diabetes mellitus is related to functional dis-
orders of neutrophils suggested the study of inflammation in streptozotocin 
induced diabetes mellitus. This study measures the neutrophilic infiltra-
tion in a simple mucosal wound in rats and the detection of nitroblue te-
trazoleum reaction of blood neutrophils within oral tissue of non-diabetic 
and diabetic rats. 
Since it has been shown that diabetics exhibit delayed healing when 
compared to non-diabetics, it is hoped that this investigation will assist 
in understanding the importance of polymorphonuclear leukocyte count dur-
ing healing of the excised wound. 
1 
LITERATURE REVIEW 
Diabetes mellitus is a hereditary or developmental disorder charac-
terized by an abnormally high level of glucose in the blood. The basic 
defect is an absolute or relative lack of insulin which leads to abnormal-
ities of carbohydrate, protein and fat metabolism. 1 
Blood sugar is normally maintained in a range approximately 80 to 
120 mg/dl. 2 Values below this range reflect hypoglycemia, whereas values 
above the range reflect hyperglycemia. Diabetes mellitus is a disease in 
which a fluctuating and often persistent hyperglycemia results in a loss 
of glucose homeostasis. Since insulin helps to control the cellular uptake 
of glucose, diabetes mellitus has occasionally been defined as a relative 
or absolute insulin deficiency. 
Insulin is normally produced by the beta cells within the pancreatic 
islets of Langerhans. Active insulin is made by progressive modification 
of preproinsulin. A rise in the concentration of blood glucose is a pri-
mary signal for secretion of insulin. The classic result of insulin action 
is a dramatic increase in the rate of transport of glucose into skeletal 
muscle and adipose tissue. Insulin also promotes the uptake of amino acids 
by skeletal muscles and increases protein synthesis. It accelerates lipid 
synthesis and inhibits lipolysis and gluconeogenisis. 3 Lack of insulin 
may result from diminished production of insulin, faulty release of in-
sulin, antibodies to insulin and/or abnormalities of the body•s cells 
precluding normal action of insulin. 4 Human insulin is a small protein 
2 
3 
with a molecular weight of 5808 and is composed of two amino acid side 
chains, connected by disulfide bridges. An important effect of insulin is 
its ability to increase the rate of glucose transport through the membranes 
of most cells in the body. In the complete absence of insulin, the over-
all rate of glucose transport becomes only one fourth the normal value. 5 
The diabetic, therefore, has high levels of blood glucose with deficient 
cellular glucose. Because of cellular glucose deficiency, the diabetic 
relies on lipids for energy, with excessive production of acetylcoenzyme A 
and ketone bodies resulting in acidosis. Coenzyme A enhances the produc-
tion of cholesterol, which, in turn, may be partially responsible for the 
increased frequency of severe atherosclerosis in diabetics. 6 
The pathology of diabetes mellitus may be related to one or more of 
the following three major effects of insulin lack: (1) decreased utilization 
of glucose by the body cells, with a resultant increase in blood glucose 
concentration; (2) markedly increased mobilization of fats from storage 
areas, causing abnormal fat metabolism and especially deposition of lipids 
in vascular walls to cause atherosclerosis; and (3) depletion of protein 
in the tissues of the body. 5 
Patients with diabetes mellitus exhibit polydipsia (excessive drink-
ing), polyuria (excessive elimination of urine), polyphagia (excessive 
eating), loss of weight and asthemia (lack of energy) as the earliest sym-
toms of the disease. Polydipsia and polyuria are due to the hyperosmolal-
ity of the blood, which results from the increased glucose levels. Gen-
eralized weakness, increased tendency to infection and poor wound healing 
are also commonly present in the initial stages.~ These symptoms of 
4 
diabetes are related to excess blood glucose and also to increased break-
down of lipids, resulting in acidosis. 
Diabetes may be experimentally produced in laboratory animals with 
injection of streptozotocin. Streptozotocin is an antibiotic extracted 
from Streptomyces acromogenes. 7 In 1963, Rakieten, et al., reported that 
streptozotocin is diabetogenic, since its intravenous administration led 
to diabetes in dogs and rats. They found that the diabetes was attributed 
to damage of the pancreatic B-cells. Junod, et al., (1963) found in their 
study that streptozotocin is an effective cytotoxic agent for pancreatic 
B cells. They found that the action occurs early, having found histologic 
evidence after 1 hour, and intense necrosis strictly limited to B-cells 
evident at 7 hours. 7 
Diabetes mellitus is often recognized as a metabolic disease that 
depresses the antibacterial defenses of the host. Many clinical investi-
gators have reported that patients with uncontrolled diabetes are unusually 
susceptible to bacterial disease. Leukocytes differ from other body cells 
in that they have the capacity to migrate, contain few mitochondria and 
metabolize glucose primarily to lactic acid. As human diabetes mellitus 
is expressed in abnormalities of carbohydrate, lipid and protein metabo-
lism1, any resulting inefficient neutrophil bactericidal and/or leukotaxis 
mechanisms may be partly responsible for the increased susceptibility of 
patients with diabetes mellitus to infection. 
The polymorphonuclear leukocytes are the most abundant of the leuko-
cytes, constituting 55% to 65% of the total count. There are about 3,000 
to 6,000 per cu. mm. or 20 to 30 billion in the circulation at any one 
5 
time. They are 10 to 12 microns in diameter and are easily recognized by 
their highly characteristic nucleus consisting of two or more lobules 
connected by narrow strands. 6 
The neutrophil is an end cell of myeloid differentiation and does 
not divide. The neutrophils arise in the bone marrow from a common an-
cestral stem cell, and after a series of divisions, undergo a maturation 
through a myeloblast, promyelocyte, metamyelocyte, band cell and mature 
PMN. After a short period in the blood (about 12 hours), the PMN•s enter 
the tissues where they complete their life span of a few days. 8 
With the maturation of the cells, there is an ·appearance of two dis-
tinct classes of granules: the primary (azurophilic) and the secondary or 
specific granules. The primary granules are electron-dense structures 
approximately 0.4 microns in diameter that appear early in maturation. 
They contain myeloperoxidase, arginine-rich basic (cationic) proteins, 
sulfated mucopolysaccharides, acid phosphatase and other acid hydrolases. 
The secondary or specific granules are not truly lysosomes; they are small-
er and less dense than primary granules. They are rich in alkaline phos-
phate, lysozyme and aminopeptidase. As maturation proceeds, the secondary 
granules increase in number and appear to predominate. Both types of 
granules are important in the breakdown of ingested material and in the 
killing of microorganisms. 8 
The life span of the neutrophils in the circulatory system is about 
seven hours. During times of tissue injury these cells can squeeze through 
the endothelial cells of the blood vessels by the process of diapedesis. 
Once the cells have entered the tissue spaces they move through the 
tissues by ameboid movement. In the tissues, the neutrophils average a 
life span of eleven days. 
6 
The mature PMN is highly specialized for the performance of its 
primary function, the phagocytosis and destruction of microorganisms. 
Several functions are required in order for the neutrophil to perform its 
task of phagocytizing foreign matter. First, the cells must reach the 
site of the foreign configuration by chemotaxis. They must then ingest 
the foreign substance by phagocytosis. Finally, after a series of meta-
bolic steps, they must destroy the foreign substance or inhibit the repli-
cation of the microorganism by microbial killing. 8 
The killing of microorganisms is the primary purpose of the phagocy-
tic system. The formation of an inflammatory exudate, composed primarily 
of neutrophils and monocytes, occurs rapidly in response to a local infec-
tion.9 Tissue damage initiates some form of stimulus which produces the 
following series of events. Neutrophils begin to marginate along the cap-
illary and venule walls in the area of tissue damage and commence to 
diapedese between the endothelial cells lining the walls. The cells are 
held up for some time at the basement membrane and then move through this 
and on toward the damaged area to which they are attracted by a chemotac-
tic stimulus. 9 
Chemotaxis appears to be mediated by substances which directly in-
fluence neutrophils, such as bacterial products or certain components of 
complement {C5, c3 and the c567 trimolecular complex) and by factors 
which interact with plasma to activate complement such as antigen-antibody 
complexes and lysosomal contents of phagocytes. 9 
7 
The trimolecular complex, c567 , exists naturally in serum in an in-
active form and can be activated by interaction in series of the other 
components of complement. The activated complex causes intense accumula-
tion of polymorphonuclear leukocytes when injected intradermally into 
rabbits. The third component of complement can produce a fragment chem-
otactic for polymorphs when acted on by plasmin. There are also various 
chemotactic factors produced by bacteria such as Dipplococcus pneumoniae, 
Staph. albus, Staph. areus and Streptococcus faecalis. 
Once the polymorph has arrived at the inflammation site, it begins 
its function of phagocytizing foreign matter. The process of phagocytosis 
is a very intricate process. The phagocytosed material is not brought 
directly in contact with the cytoplasm. The ·cytoplasmic membrane invagin-
ates and encloses the phagocytosed material within a membrane limited 
vacuole. Once the organism is taken up within the cell, the phagosome 
will come in contact with a lysosome and the two membranes will fuse. The 
lysosome will expel enzymes into the phagosome which are essential to the 
destruction of the bacterium. Before fusion with the phagosome the lyso-
some maintains a distance of 100 angstroms from the inner surface of the 
cell membrane. 9 The collision of the lysosome with the phagosome appears 
to be a 11 random hit 11 phenomena. 
Recognition by the cell that the particle is foreign is essential 
for phagocytosis to occur. The process of opsonization appears to play a 
role. Opsonins include immunoglobulins, certain components of the comple-
ment system and other plasma factors. 9 The opsonin acts upon the parti-
cle to be phagocytized, not on the phagocyte. 
8 
Exocytosis appears to be less understood but the release of metabol-
ically active and theoretically damaging materials into areas of exudate 
may contribute to tissue damage as well as being a chemotactic stimulus 
for more cells. 9 A variety of secretory products are released from the 
cell as a result of exocytosis. Some of these enzymes include hyaluroni-
dase, ribonuclease, lysozymes, histamine, leukocyte pyrogen and vitamin 
s12 binding protein. The extent of these various enzymes remains to be 
investigated. 
The metabolism of phagocytosis requires a modest expenditure of 
energy which is supplied by glycolysis and associated with increased glu-
cose utilization and lactate production. Phagocytosis and lysosomal mer-
ger with the phagosome are followed by an energy burst derived primarily 
from hexose monophosphate shunt (HMS) activation. 9 
Associated with increased HMS activity is increased production of 
hydrogen peroxide which, in the presence of myeloperoxidase, a constituent 
primarily of lysosomes, provides a potent antibacterial mechanism for the 
leukocyte. 9 The HMS is governed by the availability of NADP and the poly-
morph possesses several mechanisms for NADP regeneration. The most prom-
inent pathway utilizes NADPH oxidase where H202 is an additional product 
of the reaction. The enzyme NADPH oxidase, gives rise to H202 and NAD, 
increasing the activity in phagocytosing cells. The H202 may also inter-
act with reduced glutathione and glutathione peroxidase to give rise to 
oxidized glutathione which then may react with an NADPH linked glutathione 
reductase forming NADP for stimulation of the hexose monophosphate shunt-
glycolytic pathway and reduced glutathione. The antibacterial activity 
9 
of the H2o2-myeloperoxidase system is enhanced by small amounts of halide 
co-factors which in the case of iodide result in iodination of bacterial 
proteins and, in the case of chloride result in decarboxylation and deam-
ination of amino acids giving rise to toxic aldehydes. 9 
Nitroblue tetrazolium (NBT) is an artificial electron acceptor which 
is reduced by the PMN during the phagocytosis-induced metabolic burst. 11 
A quantitative NBT test is based on the metabolic activity of the phago-
cyte that occurs with particle uptake and intracellular digestion. The 
increased flow of protons thru the HMS shunt during phagocytosis and in-
tracellular digestion is measured calorimetrically by the reduction of 
the nitroblue tetrazolium dye to a blue formazan pigment. The NBT test 
differentiates between the resting and phagocytosing states of neutrophils. 
The quantitative NBT test is markedly depressed in cases in which there is 
an impairment in metabolic activity of leukocytes, such as in chronic 
granulomatous disease. 8 
Various factors suggest themselves as the cause of the lowered re-
sistance to infection in the diabetic. These may be summarized as follows: 
1) Increased sugar content of blood tissues. 
2) Decreased activity of blood elements associated with 
resistance to infection: (a) subnormal activity of 
complement; (b) subnormal phagocytizing capacity of 
leukocytes; (c) subnormal bacteriostatic and bacteri-
cidal action of whole blood. 
3) Inadequate functioning of fixed tissue cells. 
4) Lowered capacity of tissues to react to antigenic stimuli. 
5) Lowered state of general cellular nutrition. 12 
Adherence of granulocytes may also play a role in susceptibility 
10 
to infections in diabetics. In studies of patients with poorly controlled 
diabetes, with fasting hyperglycemia but not ketoacidosis, the mean values 
for granulocyte adherence were significantly lower than for normal control 
cells. 13 
No impairment of immunological competence has been detected in dia-
betic patients, and deficiencies in cellular defense have been demonstrated 
only in the presence of ketoacidosis, even though an insulin-correctable 
depression of glycolysis has been noted in the leukocytes of nonacidotic 
diabetics. 14 
The susceptibility to infections in diabetics could also be due to 
a delay in the granulocyte response. Perillie15 et. al., (1962) showed 
that the early granulocyte phase of local cellular response was signifi-
cantly delayed and diminished in patients with acidosis in comparison with 
normal and nonacidotic patients. 
Esmann12 (1972) in his research on the diabetic leukocyte, concluded 
that evidence points towards glucose being freely permeable to the cell 
membrane. He placed special importance on the crowding effect, i.e. the 
decrease in metabolic rate observed by increasing the cell concentration, 
in this respect. Upon placing normal and diabetic cells in a bicarbonate 
buffer at the same low concentration to avoid the crowding effect, he 
found that the glycolysis of diabetic cells is decreased. Glucose-6-phos-
phate and fructose-6-phosphate accumulate in diabetes, suggesting a de-
creased activity of phosphofructokinase. The increase in glucose-6-phos-
phate concentration is probably responsible for a small decrease in glu-
cose utilization and a slight increase in pentose cycle activity as well 
as for an increase in the relative amount of glycogen synthetized. In-
sulin in vivo corrects the metabolic alterations. 13 
11 
Martin 16 et. al., (1953) found that the cells of the diabetic subject 
have a significantly lower {p. 0.01) production of lactic acid with glucose 
and a significantly higher (p. 0.01) production with fructose. The util-
ization of glucose was significantly lower in the diabetic than in the 
control group (p. 0.02). There was a significant increase (p. 0.02) in 
utilization of glucose in the diabetic group (0.18± 0.04 micromole) on the 
addition of insulin. 16 Martin and his associates indicated that the leu-
kocyte of the diabetic subject responds to insulin by increasing lactate 
production. The effect of the metabolic defect noted in the leukocytes 
from subjects with diabetes mellitus may account for the alterations in 
susceptibility to disease. In an area of inflammation, the leukocyte of 
the diabetic subject might be unable to utilize the available glucose to 
produce bactericidal quantities of lactic acid. 13 
Munroe and Shipp 1 (1965) in their research on leukocytes and diabetes 
mellitus confirmed the results of others that the major fate of glucose in 
human leukocytes was lactic acid production. Glucose metabolism in leu-
kocytes from diabetics differed in two respects. The per cent of glucose 
uptake oxidized in the pentose cycle was increased in leukocytes from all 
diabetics. In the insulin-treated diabetics glucose uptake and lactic 
acid formation were similar to controls. In contrast, glucose uptake and 
lactic acid formation were reduced in leukocytes from adult, latent, hy-
percholesteremic diabetics. Pyruvate and acetate oxidation was similar 
in diabetics and controls. Thus, in terms of leukocyte metabolism, 
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hypercholesteremia in the human diabetic was correlated with reduced gly-
colysis and not with reduced pentose cycle activity. 1 
Dumm 17 (1957) only found reduced glucose utilization in cells from 
patients with the most severe diabetes, and explained this finding by ob-
serving that plasma from diabetics was able to inhibit the glucose utili-
zation of normal leukocytes. 
Esmann 18 (1964) in his experiment on the effect of cell concentration 
on the metabolism of normal and diabetic leukocytes in vitro, showed an 
overall decrease of glucose uptake, lactic acid production and glycogen 
synthesis in human diabetic leukocytes. 
The marked increase in glycogen which occurs during the course of an 
inflammatory response in normal animals is due to the high glycogen con-
tent of the invading leukocytes. The glycogen content increases in the 
diabetic animal to an even greater extent than in the normals, due to the 
nature of the disease. Because the leukocytes from diabetic animals were 
found to have the same glycogen content as leukocytes from normal animals, 
it appears that, once leukocyte invasion begins, more cells enter the ex-
perimental site per unit time and that the duration of leukocyte invasion 
is increased, compared to nondiabetic animals. 19 
Dumm17 (1957) found that although glucose utilization by leukocytes 
from diabetic humans was impaired, there was no reduction in lactate pro-
duction. 
Insulin binds to the surface of leukocytes. The effect of insulin 
in vitro on glucose utilization and glycolysis has been sought for, but 
with controversial results. 
13 
Martin 16 (1953) found an increased glucose utilization and lactic 
acid formation with 0.1 U insulin/ml in diabetic, but not in normal cells. 
Esmann 20 (1963) found a significant increase in glucose utilization, 
lactate and glycogen formation after 24 hours of treatment of diabetic 
patients with insulin. 
The decreased rate of glycolysis in diabetic cells can be attribu-
table to concentrations of essential enzymes. The diabetic leukocytes 
have high concentrations of glucose and fructose-6-phosphate, which are 
normalized upon treatment of the patients with insulin. This suggests a 
decreased activity of the phosphofructokinase reaction in uncontrolled 
diabetes and may explain the decreased rate of glycolysis found in diabet-
ic cells. 13 Esmann attributes the limited Kreb's cycle activity to the 
paucity of mitochondria in human polymorphonuclear leukocytes. 
Marble 21 (1952) hypothesized that the subnormal phagocytizing capa-
city of the leukocyte was one of the possible causes of reduced resistance 
of the diabetic to infection. 
Wertman and Henney22 (1961) in their study on phagocytosis in diabet-
ic leukocytes indicated that the animals with alloxan-induced hypergly-
cemia had an impaired defense mechanism. The rats with high concentrations 
of blood sugar had not only a lower percentage of active neutrophils but 
the activity of these cells was considerably reduced. The alloxan diabetic 
rat demonstrated an average of 45% and 42% active neutrophils and the rats 
with a normal sugar concentration an average of 91%, 87% and 88%. The 
active neutrophil of the alloxan diabetic animal engulfed on the average 
4 microorganisms per neutrophil as compared to 17 microorganisms per 
14 
neutrophil of the rat with a normal sugar concentration. It appeared evi-
dent that rats injected with sufficient alloxan to cause hyperglycemia 
were reduced in the capacity to phagocytize bacteria. 13 
In 1974, Robertson and Polk, in their study on leukocyte malfunction 
showed that hyperglycemia alone led to decreased phagocytosis, decreased 
diapedesis and a decrease in intracellular killing of bacteria by PMN's. 
They theorized that an intrinsic defect in the PMN was a cause of the mal-
function. They also found that there was no significant difference in 
immunoglobulins A, G and M on the surface of diabetic and normal PMN's; 
and that the metabolic pathways are altered in diabetic PMN's which may 
cause a malfunction in their ability to affect infectious organisms. 
Bybee and Rogers 23 (1964), in their study on the phagocytic activity 
of polymorphonuclear leukocytes obtained from patients with diabetes mel-
litus, suggest that PMN leukocytes obtained from nonacidotic diabetic pa-
tients exhibit normal phagocytic activity. In contrast, leukocytes ob-
tained from diabetic patients in ketoacidosis showed suppression of their 
ability to ingest a pathogenic Staphylococcus. This abnormality was 
corrected when the acidosis was corrected. This quantitative decrease in 
phagocytic capacity appeared to be the result of an abnormality of the 
diabetic leukocyte. 
Drachman 2 ~ et. al., (1966) showed that the phagocytic capabilities of 
polymorphonuclear leukocytes are affected by the high levels of glucose in 
the tissues of chronically diabetic rats. In the intact diabetic animal, 
not only did the histological and quantitative bacteriological findings 
suggest a depression of phagocytosis, but an impairment of in vivo 
15 
phagocytic activity was also demonstrated in a preformed inflammatory ex-
udate. Also noted was that the principal defect in the diabetic animals 
resided in their serum rather than in their polymorphonuclear leukocytes. 
The depressive factor in the serum was identified as the abnormally high 
concentration of glucose. 
Contrary work was shown by Miller and Baker25 (1972). Although hy-
perglycemia has been found to depress in vitro phagocytosis of pneumococci 
in diabetic rats and poorly controlled diabetic patients, no correlation 
between neutrophil function and blood glucose levels in juvenile diabetic 
patients was demonstrated. 
It has been reported that leukocytes from rabbits with acute alloxan 
diabetes and acidosis had reduced bactericidal power for engulfed pneumo-
cocci.26 Richardson 27 (1933) felt that the reduced bactericidal power of 
whole blood in his studies was directly related with the presence of acid-
osis. 
The metabolic changes following phagocytosis have not been extensive-
ly investigated in diabetic leukocytes, but it has been reported that the 
mobilization of glycogen during phagocytosis is impaired in alloxan-diabet-
ic rat cells. For the intracellular killing of bacteria, the formation of 
H2o2 in the pentose cycle is of importance. It is, therefore, essential 
that the normal increase in pentose cyc~e activity upon phagocytosis is 
not impaired in diabetic rat or human leukocytes. 13 
Cantonzaro-Guimaraes 28 (1968) noted that the diabetic animals exhib-
ited an increased acute inflammatory cell population, primarily in the 
form of PMN's. 
16 
Leukocyte chemotaxis is the ability of the neutrophil to move uni-
directionally toward an increasing chemotactic stimulus. Many investiga-
tors have demonstrated impaired leukocyte chemotaxis in diabetes mellitus. 
Steerman29 et. al., (1971) described normal chemotaxis as a consequence of 
chemotactic factors derived from serum interacting with cells capable of 
responding to these factors. He described impairment of chemotaxis as the 
primary result of an intrinsic defect of polymorphonuclear leukocytes. 
These impairments of PMN function were demonstrated by an inability of the 
patient•s PMN•s to respond to chemotactic factors in •activated• whole 
serum or in preparations of C5a. Since these abnormalities were not cor-
rected by the addition of normal serum or plasma to the patient•s cells, 
the deficiency in chemotaxis could not be accounted for solely by a defi-
ciency of a humoral factor. Steerman and associates also theorized that 
since this patient had normal or elevated levels of haemolytic activity for 
total complement and the individual components of C1 through C5 and failed 
to show correction of PMN function with the addition of normal serum, that 
it is improbable that an abnormality of the complement system is respons-
ible for his defects in PMN function. 
Miller 30 et. al., (1973) in his research on leukocyte mobility and 
Lazy Leukocyte Syndrome (LLS), concluded that on the basis of current 
knowledge of the mechanisms involved in chemotaxis and random mobility, 
it seems possible that the basic defect in the familial disorder involves 
specific chemotactic receptor(s), while that of the LLS may involve a less 
specialized aspect of leukocyte integrity, perhaps a membrane defect. 
Hill 31 et al., (1974) in their study on impaired leukocyte 
17 
responsiveness in diabetes mellitus showed that leukocytes of patients 
with juvenile onset diabetes mellitus responded less actively than con-
trols in unidirectional movement toward a chemotactic stimulus. Neither 
abnormalities of serum concentrations of cholesterol, triglycerides, glu-
cose and creatine, nor the duration of the diabetic state had an apparent 
effect on the presence or severity of the leukotactic abnormality. 
Ward and Becker32 (1970) have shown that leukotaxis is impaired when 
there is a depletion of intracellular potassium. They theorized that in-
sulin, in the presence of glucose, may act upon enzyme systems resulting 
in an influx of potassium and enhancing the ability of leukocytes of dia-
betics to respond to a chemotaxis stimulus. 
Goetzl and Austen 33 (1974) found that several chemotactic factors 
increased both aerobic glycolysis and metabolism through the hexose mono-
phosphate shunt. Their investigation indicates that suppression of both 
the HMPS and glycolysis inhibits chemotactic migration of polymorphonu-
clear leukocytes. 
A study of leukocyte functions in juvenile diabetes mellitus by 
Miller and Baker25 (1972) found that chemotaxis of polymorphonuclear leu-
kocytes from children with juvenile diabetes who had received insulin was 
not improved. They explained the deficiency in generation of chemotactic 
activity in that children might have increased amounts of circulating 
antigen-antibody complexes due to the production of anti-insulin antibod-
ies. They theorized that these complexes might, then, activate the com-
plement system, thus resulting in less available complement molecules for 
generation of chemotactic activity. 
18 
Mowar and Baum 3 ~ (1971) using an in vitro method of measuring the 
chemotaxis of polymorphonuclear leukocytes from peripheral blood calculat-
ed a chemotactic index. The mean chemotactic index in 31 patients with 
diabetes mellitus was significantly less (p. less than 0.0005) than that 
in 31 matched controls. They found that the defect in chemotaxis could 
not be correlated with plasma insulin, plasma glucose, serum C02 and blood 
urea nitrogen values or with any therapeutic agents. The defect in chemo-
taxis of the diabetic leukocytes was corrected by incubation of the cells 
with insulin. Insulin was found to be ineffective in the absence of glu-
cose. 
Golub 35 et al., (1982) found in their study that diabetes in rats 
inhibits the migration of neutrophils into the healing gingival crevice. 
A decreased crevicular leukocyte response in vivo was detected as early 
as 4 days after diabetes was induced. 
Manouchehr 36 et. al., (1981) in their study on PMN chemotactic re-
sponse in diabetic patients and periodontal disease demonstrated that 
diabetic patients and severe periodontitis have significant impairment of 
PMN chemotaxis. In contrast, diabetic patients and mild periodontal dis-
ease as well as nondiabetic subjects and either severe or mild periodon-
titis did not show such impairment. They indicated that the impairment 
of PMN chemotaxis may be important in the pathogenesis of server periodon-
titis in diabetic patients. 
It is commonly stated that patients with diabetes mellitus are more 
susceptible to infections. It appears that in the diabetic patient the 
function of leukocytes in inflammation is hampered. A decrease in 
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glycolysis, inability of the diabetic leukocyte to phagocytize and a de-
fect in leukotaxis can play a role in abnormal leukocyte function; or a 
multifactorial problem may be evident. These abnormalities of the leuko-
cyte could contribute to increased infections in the uncontrolled diabetic 
patient. 
The evidence that diabetes mellitus is related to functional dis-
orders of neutrophils suggested the study of inflammation in streptozoto-
cin induced diabetes mellitus. This study measures the neutrophilic in-
filtration in a simple mucosal wound in rats and the detection of nitroblue 
tetrazolium reaction of blood neutrophils. 
MATERIALS AND METHOD 
Eight male Holtzman* rats, averaging 250 grams each in weight, were 
divided into two groups: Control group A and experimental group B. All 
animals were housed separately to help minimize stress and the possibility 
of cross infection. They were maintained on Purina Rat Chow** and water. 
The water was contained in a graduated bottle and was available ad libitum. 
The daily water consumption for each animal was recorded. 
The control group A consisted of four rats which were not injected 
with streptozotocin.*** The experimental group B consisted of four rats 
which were intraperitoneally (I.P.) injected with streptozotocin (65 mg/kg 
in lee citrate buffer solution). The animals were anesthetized using 
diethyl ether to aid in injecting the streptozotocin. 
The streptozotocin was weighed out (0.02 grams) and placed into each 
of four small dark bottles. A citrate buffer solution was prepared for 
addition to the streptozotocin. Two solutions were initially made. Solu-
tionA, consisted of 1.382 grams Na citrate diluted with 100 ml. NaCL 9.9%. 
In solution B, 1.114 grams of citric acid were diluted with 100 ml :of 0.9% 
NaCL. Solution A was added to solution B until a pH of 4.5 was obtained. 
A lee Tuberculin syringe was filled with the prepared citrate buffer 
solution and injected into the dark bottle containing 0.02 grams of 
* Lock-Ericson Labs, Melrose Park, Illinois 
** Scientific Small Animal Co., Arlington Heights, Illinois 
*** Upjohn Co., Kalamazoo, Michigan 
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streptoxotocin. The contents was then mixed thoroughly and lee of the 
mixture was withdrawn by syringe. The lee streptozotocin mixture was 
then injected I.P. into the anesthetized animal. The animal was then re-
turned to its respective cage for recovery. 
After seven days all the animals within group B were weighed and 
clinically evaluated for diabetes mellitus. The criteria recorded in 
evaluating the diabetic state of the experimental animals were: increased 
water consumption (the percent of consumption was estimated daily thru 
the use of the graduated water bottle), glucosuria (evaluated thru use of 
Tes-Tape* on a urine sample) and hyperglycemia (evaluated through use of 
Dextrostrip** on a blood sample). The above diagnostic tests were also 
made with control group A to insure that these animals were not diabetic. 
Linear incisions 0.5 em. in length were made in the palatal attached 
incisions 0.5 em in length were made in the palatal attached gingivae and 
extended posteriorly to the left maxillary incisor in each rat. An Amer-
ican Standard 20/21 scalpel was utilized to make the incisions. 
One member of each group was sacrificed with a lethal dose of diethyl 
ether at the following intervals: 3, 6, 12 and 24 hours postoperatively. 
The surgical and corresponding non-surgical site of attached gingi-
vae were removed by block dissection. The tissue samples were fixed in 
10% neutral formalin for eight hours and prepared by conventional histo~ 
logic techniques for evaluation. The specimens were washed in tap water 
overnight, dehydrated in ascending alcohols, cleared in xylene and embedded 
* Lilly Co., Indianapolis, Indiana 
**Ames Co., Elkhart, Indiana 
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in paraffin blocks. Ten sections approximately six microns in thickness 
were obtained from each specimen site and were stained with hematoxylin 
and eosin (Hand E) in order to obtain a microscopically measureable com-
parison of the healing sites between groups A and B. 
Blood samples were taken at the time of sacrifice and thin smears 
were prepared on slides and stained using NBT* procedure. 0.1 ml NBT 
solution (Reagent A') was transferred to a siliconized vial. 0.1 ml of 
well mixed heparinized blood was added to the vial and mixed gently by 
rolling the vial. The vial was incubated at 37°C for fifteen minutes then 
removed and let stand at room temperature an additional fifteen minutes. 
The heparinized blood-NBT mixture was transferred onto a clean glass slide 
and a smear was made. The slides were then stained with Wright stain. 
Polymorphonuclear leukocyte (PMN) counts were made from each tissue 
specimen by counting the numbers of neutrophils within a 300 micron square 
area along the edge of the incised wound beneath the level of epithelium. 
The corresponding control tissue sections similarly were quantitatively 
evaluated and recorded. 
The blood slides were examined and evaluated for positive or negative 
NBT activity within each group. 
The sections from the gingival wounds were stained with H and E and 
were examined with an A0-10 Star** microscope at a 450X's magnification. 
The connective tissue in the lamina propria immediately adjacent to the 
incision was selected for counting PMN's. An ocular eyepiece with a 100 
* NBT test, Sigma Co., St. Louis, Missouri 
** AO Co., Buffalo, Ney York 
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micron square reticular was used as a guide in scanning the connective 
tissue. All counts were made within 300 microns parallel to the cut sur-
face of the lamina propria. PMN's were identified and microscopic counts 
from nine 100 micron square fields were recorded. The mean per 100 micron 
square was calculated and recorded. 
The NBT activity in the blood smears were recorded only according 
to the frequency of NBT positive or negative PMN's in each of the speci-
mens, per 100 micron square field. 
RESULTS 
The four rats injected with streptozotocin were diagnosed as diabet-
ic. Each diabet1c animal demonstrated increased water consumption (Table 
1), an elevated blood glucose level (Table 2) and glucosuria. 
The average water consumption for the control group was approximate-
ly 8% of total water volume per day. The average water consumption for 
the diabetic group was approximately 12% of the total water volume per day. 
Blood glucose levels for control and diabetic animals were deter-
mined using Dextrostix, expressed in mg. glucose/dl. blood. All control 
animals fell into the 90 mg. glucose/dl. blood range (Table 2). Three of 
the diabetic ani~als (3-0, 12-D and 24-D) had blood glucose levels of 175 
mg. glucose/dl. blood, and one (6-D) had a blood glucose level of 130 mg. 
glucose/dl. blood (Table 2). The Tes-tape analysis of urine samples for 
the control group was normal. For the diabetic animals the urine sugar 
level was markedly elevated. 
PMN counts for both groups can be found in Table 3 and Figures 1, 2 
and 3. The average number of PMN 1 s per 100 micron squared for the control 
group ranged from 19.3 PMN 1 s per 100 micron squared for the 3 hour animal 
to the maximum number at 6 hours (27.8 PMN 1 s per 100 micron square). In 
the diabetic group the 3 hour value was the lowest (11.0 PMN•s per 100 
microns squared) and the maximum value was reached at the 12 hour interval 
(26.0 PMN 1 s per 100 micron squared). 
As seen in Table 4, the NBT test of the blood smear was positive for 
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Figure 1 - Frequency distribution of polymorphonuclear leukocytes 
at the site of gingival incision wounds per 100 micron 
squared field ~n control group. 
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Figure 2 - Frequency distribution of polymorphonuclear leukocytes 
at the site of gingival incision wounds per 100 micron 
squared field in diabetic group. 
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the entire control and diabetic groups. 
The findings in this experiment were not subJected to statistical 
analysis. 
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Table 1 - Daily water consumption for control and diabetic 
animals, ml. %consumed daily over a seven day 
period using a calibrated water bottle. 
Animal # DAYS Ave. 
day 
1 2 3 4 5 6 7 
1-Control 10 5 5 10 5 10 5 7 
2-Control 10 10 10 10 5 5 10 8 
3-Control 10 10 10 10 10 10 5 9 
4-Control 5 10 5 10 10 10 10 8 
5-Diabetic 10 20 10 10 20 10 10 12 
6-Diabetic 20 20 10 10 20 5 10 13 
7-Diabetic 15 15 15 15 10 10 10 12 
8-Diabetic 10 10 20 10 15 15 10 12 
Table 2 - Approximate blood glucose level in control and 
diabetic animals, using Dextrostix {mg. glucose/ 
dl. blood). 
Animal # mg. glucose/dl. blood 
1-Control 90 
2-Control 90 
3-Control 90 
4-Control 90 
5-Diabetic 175 
6-Diabetic 130 
7-Diabetic 175 
8-Diabeti c 175 
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Table 3 - Polymorphonuclear leukocytes in healing incision 
wounds of the gingivae in nine 100 micron squared 
fields. 
CONTROL DIABETIC 
21 13 
16 15 
17 9 
20 12 
3 hr. 23 Ave.= 19.3 7 Ave.= 11.0 
27 18 
14 10 
25 4 
11 11 
35 19 
26 13 
24 15 
30 21 
6 hr. 27 Ave.= 27.8 17 Ave.=16.3 
22 20 
31 14 
29 10 
27 18 
26 31 
30 33 
18 27 
24 19 
12 hr. 27 Ave.= 23.6 26 Ave.= 26.0 
21 23 
32 17 
28 30 
16 28 
21 24 
16 13 
13 18 
10 16 
24 hr. 23 Ave.=16.6 21 Ave.= 18.4 
18 20 
15 17 
19 15 
17 22 
Table 4 - Qualitative results of NBT test in blood smears -
Control vs. Diabetic. 
HOUR 
3 hr. 
6 hr. 
12 hr. 
24 hr. 
CONTROL 
+ 
+ 
+ 
+ 
DIABETIC 
+ 
+ 
+ 
+ 
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DISCUSSION 
Four rats injected intraperitoneally with streptozotocin exhibited 
clinical signs of diabetes mellitus after seven days. Over this seven day 
period the daily water consumption for the diabetic rats significantly in-
creased in comparison to the non-diabetic animals. The streptozotocin in-
duced diabetic rats consumed an average of 12 ml of water daily while the 
non-diabetic rats consumed an average of 8 ml of water daily. This poly-
dipsia was a result of the increase in blood glucose in the diabetic rats. 
The diabetic rats exhibit marked increases of glucose in the blood 
and urine as measured with Tes-tape and Dextrostix, with this increase in 
glucose indicative of a diabetic state. The normal range for blood glucose 
is approximately 80-120 mg/dl. 37 The control animals blood glucose level 
is 90 mg/dl and falls into the normal range. Three of the four experimen-
tal rats had blood glucose levels of 175 mg/dl, while the fourth rat had a 
blood glucose level of 130 mg/dl, all of which are above the normal range. 
Additional evidence of diabetes in the rats is the excessive glucose in the 
urine. 
This study confirms the results of Rakieten, et. al., in 1963 that 
diabetes may be experimentally produced in laboratory rats by the intra-
peritoneal injection of streptozotocin, which causes pancreatic islet beta 
cell necrosis. The rats exhibited abnormally high blood and urine glucose 
levels, polydipsia, polyuria and polyphagia. This destruction of the pan-
creatic beta cells results in an increased blood glucose level due to a 
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lack of insulin. 
The increase in water consumption by the diabetic rats in this study 
can be attributed to the elevated blood sugar levels. Guyton (1976) states 
' 
that the elevated. blood glucose has a dehydrating effect on the tissue 
cells. The elevated blood glucose has an osmotic diuretic effect on the 
kidney tubules, resulting in polyuria. Hence, the polydipsia is due to de-
hydration resulting from polyuria. 
Infiltration of polymorphonuclear leukocytes into the healing wound 
of streptozotocin induced diabetic rats parallels those studies done by 
Hill, Perillie, Ward aDd Becker, and Robertson and Polk. When compared to 
the non-diabetic rats, the streptozotocin induced diabetic rats exhibit a 
delay in polymorphonuclear leukocyte response. This difference appears to 
manifest itself in the early stages of wound healing. There is a greater 
difference of PMN leukocyte response between the diabetic and non-diabetic 
rats in the 3 hour wound (an average difference of 8 PMN 1 s per 300 X 300m2 
area) and the 6 hour wound (an average difference of 11 PMN•s per 300 X 300 
m2 area). At 3 and 6 hours the wounds in the non-diabetic animals had a 
greater infiltration of PMN 1 s in the same corresponding wounds compared to 
the diabetic animals. However, in the 12 hour and 24 hour wound sites, 
there appears to be no significant difference in PMN leukocyte response be-
tween the diabetic and non-diabetic rats. Interestingly, this delay of 
PMN leukocyte response in the diabetic rats as seen in the early stages of 
wound healing is not evident as the wound healing process progresses. This 
early delay in PMN leukocyte response in the diabetic animal may be attrib-
uted to a variety of factors, none of which is conclusive. 
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Hill {et. al., 1973) in his study on impaired luekocyte responsive-
ness, suggests a deficient chemotactic stimulus may cause the delay in 
leukocyte response. If this is the case in this study, evidently the che-
motactic stimulus, while inhibited at the early phases of wound healing in 
the diabetic rats, becomes restored as the wound healing phenomena progres-
ses. Similarly, if the delay in PMN leukocytes response is attributed to 
deficient chemotactic factors, then an increase or pronounced expression of 
such chemotactic factors may account for the increase in PMN leukocyte re-
sponse in the 12 hour and 24 hour wounds. An explanation for this change 
in neutrophil chemoattraction is suggested by Ward {1970), that upon des-
truction or death of the PMN at the site of inflammation, lysosomal factors 
are released which are chemotactic for PMN's. This may account for the in-
crease in PMN response at the later stages of wound healing. 
Perillie {et. al., 1962) shows that the early granulocyte phase of 
local cellular response is significantly delayed and diminished in patients 
with acidosis in comparison with normal and non-acidotic patients. In this 
study the delay in PMN leukocyte infiltration into the healing wounds of 
diabetic rats as compared to non-diabetic rats may also be due to acidosis. 
As the streptozotocin induced diabetic rats all show severe clinical signs 
of diabetes, the associated acidosis may in part be a factor for the early 
delay of PMN leukocytes at the healing wound site. 
Ramamurthy and co-workers {1979) in their research found that diabetes 
inhibits the migration of PMN's into the rat gingival crevice during the 
early inflammatory phases of wound healing. This is consistent with the 
results in this study. The migration of PMN's in the diabetic animals is 
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inhibited during the early phases of wound healing. The PMN response dur-
ing the later stages of wound healing in the diabetic animals appears to 
increase, more closely approximating the PMN response in the control ani-
mals. This initial delay of PMN migration in the diabetic animals during 
the early stages of wound healing may be due to a number of factors. Ward 
and Becker in 1970, showed that leukotaxis is impaired when there is a de-
pletion of potassium. They theorize that the decreased potassium concen-
tration in the extracellular fluid of diabetics in the acidotic state, may 
inhibit enzyme systems reducing the ability of the leukocytes of diabetics 
to respond to a chemotaxis stimulus. However, their theory does not account 
for the correctable PMN response seen at the later stages of wound healing 
in this study. 
Marble (1952), and Wertman and Henney (1961) in their studies hypoth-
esized that the subnormal phagocytizing capacity of the leukocyte was one 
of the possible causes of reduced resistance of the diabetic to infection. 
Robertson and Polk (1974) showed that hyperglycemia alone led to decreased 
phagocytosis, decreased diapedesis and a decrease in intracellular killing 
of bacteria by PMN's. Drachman (et. al., 1966) showed that the phagocytic 
capabilities of PMN's are affected by the high levels of glucose in the 
tissues of chronically diabetic rats. 
This study parallels the results reported by Miller and Baker. As 
there appears to be no observable defect of phagocytosis in the diabetic 
and non-diabetic rats as measured by the NBT test. Both diabetic and non-
diabetic rats exhibited the reduction of nitroblue tetrazolium dye to a 
blue formazan pigment. Moreover, this positive NBT test for phagocytosis 
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was exemplified at both early and later stages of wound healing. 
SUMMARY AND CONCLUSIONS 
Eight male Sprague Dawley rats were experimentally made chemically 
diabetic by injecting streptozotocin. Seven days after the injection of 
the diabetogenic agent, the rats were clinically diagnosed as having dia-
betes mellitus. The diagnosis was confirmed by polydipsia, glycosuria, 
hyperglycemia and loss of weight. 
The diabetic and non-diabetic animals were then subjected to a pala-
tal incision wound and sacrificed at the following time intervals: 3, 6, 
12 and 24 hours. The corresponding tissue sections were excised and fixed 
in 10% formalin and prepared according to conventional histologic technique 
utilizing hematoxylin and eosin staining procedures. Polymorphonuclear 
leukocyte (PMN) counts were made from each tissue specimen by counting the 
numbers of neutrophils within a 300 micron square area along the edge of 
the incised wound beneath the level of epithelium. The corresponding con-
trol tissue sections similarly were quantitatively evaluated and recorded. 
Blood samples were taken at the time of sacrifice and thin smears 
were prepared and stained using NBT procedure. The blood slides were ex-
amined and evaluated for positive or negative NBT activity within each 
group. 
The following conclusions can be drawn from this study: 
1) Diabetes can be produced experimentally in rats thru the 
intraperitoneal injection of streptozotocin. 
2} Rats made diabetic exhibit polydipsia, glycosuria, 
hyperglycemia and loss of weight. 
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3) There appears to be a delay in the response of PMN's 
to the site of wound healing within 3 and 6 hour 
post-injury diabetic rats. 
4) The delay of PMN's in diabetic animals appears to 
correct itself within 12 to 24 hours post-injury. 
5} There appears to be no defect in the diabetic or 
non-diabetic rats as to the ability of their PMN's 
to phagocytize. 
38 
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